Back to ROYCE & ASSOCIATES LP

CPRX
Showing 8 of 26 quarters

Position history for ROYCE & ASSOCIATES LP's holdings in CATALYST PHARMACEUTICALS INC

ROYCE & ASSOCIATES LP holds 2.1M shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $51.7M as of 2026-Q1. The position was increased (+9.4% shares). CPRX represents 0.5% of ROYCE & ASSOCIATES LP's portfolio.

Current Value

$51.7M

Current Shares

2.1M

Total Value Change

+$18.3M

Total Shares Change

-72,116

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.1M
+9.4%
$51.7M0.5%$23.92
45
2025-Q4
Decreased
1.9M
-6.1%
$44.6M0.5%$23.29
0
2025-Q3
Increased
2M
+28.6%
$40.1M0.4%$19.55
44
2025-Q2
Decreased
1.6M
-1.0%
$34.3M0.4%$21.78
0
2025-Q1
Decreased
1.6M
-14.3%
$38.8M0.4%$24.69
0
2024-Q4
Decreased
1.9M
-7.8%
$38.9M0.4%$21.07
0
2024-Q3
Decreased
2M
-6.5%
$40.2M0.4%$19.56
0
2024-Q2
Increased
2.2M
+3.7%
$33.5M0.3%$15.49
36

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used